Moxifloxacin Tad

Moxifloxacin, the active ingredient in Moxifloxacin Tad, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections, particularly respiratory and skin infections, in adult patients. The drug works by targeting bacterial DNA processes, providing broad‑spectrum coverage against Gram‑positive and Gram‑negative pathogens.

GNH USA supplies Moxifloxacin Tad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across European and global markets.

Moxifloxacin is indicated for several bacterial infections affecting the respiratory tract and skin.

- Community‑acquired bacterial pneumonia: achieves clinical cure and microbiological eradication. - Acute bacterial sinusitis: reduces symptoms and clears the infection. - Acute bacterial exacerbation of chronic bronchitis: improves airflow and resolves bacterial load. - Skin and skin structure infections: eliminates pathogenic bacteria and promotes healing.

Moxifloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: loose stools, usually self‑limiting. - Headache: mild to moderate intensity. - Dizziness: sensation of light‑headedness.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in weight‑bearing tendons. - QT prolongation: potential cardiac arrhythmia risk. - Severe allergic reaction: anaphylaxis, angioedema, or skin rash requiring immediate medical attention.

When prescribing Moxifloxacin, clinicians should consider several safety precautions to minimize risk.

- Renal function: assess before initiating therapy. - Tendon health: advise patients to report tendon pain or swelling promptly. - QT interval: avoid use in patients with known prolongation or concurrent QT‑prolonging drugs. - Elderly patients: monitor closely for CNS effects and dosing adjustments. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Moxifloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids or supplements containing magnesium, aluminum, calcium, or iron: reduce absorption of moxifloxacin. - Drugs that prolong QT interval (e.g., quinidine, amiodarone): increase risk of cardiac arrhythmias. - Warfarin: may enhance anticoagulant effect and raise INR.

Moderate Interactions (Monitor Closely): - Corticosteroids: combined use may increase risk of tendon rupture. - Theophylline: may raise plasma concentrations, requiring dose adjustment.